Introduction
Bone regeneration is required to repair mandible defects arising from trauma, inflammation, or tumor. Stem cellbased gene therapy for enhancing bone formation is becoming a primary approach in bone tissue engineering, because stem cells have the capability to express the transgene for affecting the cells themselves and recruiting host stem cells to achieve bone formation [1, 2] . Moreover, this approach can eliminate the donor-site pain, limited availability of autologous grafts and immunogenicity of allogenic grafts, and reduce the surgery time [3] [4] [5] . Bone marrow stem cells (BMSCs) are pluripotent cells having the potential to differentiate into bone, cartilage, muscle, and ligament [6, 7] . A previous study has reported that the cultured BMSCs with genetic modification through adenovirus-bone morphogenetic protein 2 (BMP2) can produce orthotopic bone in the hindlimbs of mice [8] . However, the genetically modified osteogenic stem cells with over-expressed osteogenic factors were less effective in treating large bone defects due to inefficient blood supply in the entire bone graft. In order to gain an insight into the vascularization process, the co-culture methods with angiogenic cells have been established. One potential approach to achieve such vascularization was the application of endothelial progenitor cells (EPCs), which have two different types (early EPC and late EPC) according to their time-dependent appearance [9, 10] . The transplantation of EPCs resulted in an obviously improved blood flow recovery in experimentally induced hind limb ischemia of mice [11] . However, the therapeutic strategy using EPC transplantation is still hampered by the scarcity of these progenitor cells [12] . Vascular endothelial growth factor (VEGF)-modified EPC gene transfer offered an attractive strategy to overcome the problem of insufficient amount of EPCs [12, 13] . BMP2 and VEGF are the primary factors in the cellular communication during angiogenesis and osteogenesis [14] . In vitro studies have revealed a BMP/ VEGF-regulated coupling in bone regeneration [15] . A synergistic effect between BMP2 and VEGF may play important roles in enhancing the efficiency of cell-based and gene-based approaches for bone regeneration, while its potential negative effects should not be neglected.
In this study, we combined scaffolds with Ad-BMP2-BMSCs and Ad-VEGF-EPCs, trying to improve the vascularization of the graft and to accelerate ectopic bone formation. We also observed the negative effect of this approach on final bone regeneration and explored the possible reasons.
Materials and Methods
Isolation and culture of EPCs and BMSCs from rat bone marrow Wistar male rats (3 -4 weeks) with weight of 130-140 g were used for isolating BMSCs and EPCs, as described previously [16] . Mononuclear cells (MNCs) from femurs and tibias bone marrow aspirate were isolated by using a Percoll (Sigma, St Louis, USA) density gradient separation method (1200 g for 20 min) at room temperature. After centrifugation, the cells were washed twice with phosphatebuffered saline (PBS), and then suspended in different cell culture medium. For BMSCs differentiation, MNCs were cultured in low-glucose Dulbecco's modified Eagle's medium (L-DMEM) (Gibco Brl, Eggenstein, Germany) containing 10% fetal bovine serum (FBS), 10 IU/ml penicillin, and 10 mg/ml streptomycin. For EPCs differentiation, MNCs were cultured in endothelial growth medium (EGM-2) supplemented with the additives of rhEGF, VEGF, rhFGF-B, R3-IGF-1, ascorbic acid, heparin from growth factor bullet kit (Lonza, Cologne, Germany), 2% FBS, 10 IU/ml penicillin, and 10 mg/ml streptomycin. MNCs were plated into 75 cm 2 tissue culture flask at a density of 1 Â 10 6 cells/ml. After 24 h incubation at 378C in a humidified atmosphere with 5% CO 2 , nonadherent cells were removed and fresh medium was added to the flask. The medium was changed every 3 days. After 5-7 days, the adhered cells with 90% confluence were split for passage at a ratio of 1:3.
Immunophenotype and function of rat EPCs
EPCs from passage 3 were seeded on human fibronectincoated six-well plates at a density of 2 Â 10 5 cells/well. On the next day, the expression of surface markers of cultured cells was determined by using flow cytometry. The cultured cells were washed with PBS and incubated with rat monoclonal antibodies against VEGF receptor 2 (VEGFR2; BioLegend, San Diego, USA), CD133 (Abcam, Cambridge, UK) and phycoerythrin (PE)-conjugated CD34 (Santa Cruz Biotechnology, Santa Cruz, USA) at room temperature for 30 min. In order to detect VEGFR2 and CD133, the cells were further incubated with an isotype-specific PE-Cy 5.5-conjugated (Invitrogen Life Technologies, Carlsbad, USA) and fluoresceinisothiocyanate (FITC)-conjugated (eBioscience, San Diego, USA) goat anti-rat antibodies. Quantitative analysis was performed using CellQuest Pro Software (BD Biosciences, San Jose, USA) on a flow cytometer.
Capillary morphogenesis assay and uptake of Dil-acetylated low-density lipoprotein (Dil-ac-LDL) assay were used to observe the function of EPCs. One hundred microliters of Matrigel (BD Biosciences) at a concentration of 10-12 mg/ml was added into a 96-well plate and polymerized at 378C for 30-60 min. The EPCs were plated onto the Matrigel (5 Â 10 3 cells/ml) in EGM-2 medium and incubated at 378C for 2 h. Early passage (1 -2) EPCs (2 Â 10 5 cells/well) were seeded on human fibronectin-coated six-well plates. On the next day, the attached cells were incubated with 10 mg/ml Dil-ac-LDL (Biomedical Technologies Inc., Stoughton, USA) in EGM-2 complete medium at 378C for 4 h. The cells were then washed three times with PBS and stained with FITC-Letin (Vector Laboratories, Burlingame, USA). The cells were visualized by using fluorescence confocal microscope.
Gene transfer
The adenoviral vectors were designated Ad-BMP2, Ad-VEGF, and Ad-GFP, which were E1-deficient recombinant adenovirus propagated in 293 cells and purified by cesium chloride gradient ultracentrifugation as described earlier [17] . Optimal conditions for adenovirus gene transfer serum concentration, virus incubation time and virus concentration in EPCs and BMSCs were evaluated by preliminary experiments. The cells were transduced with 40 multiplicity of infection of Ad-BMP2, Ad-VEGF, and Ad-GFP for 48 h in the culture media containing 1% FBS. After transduction, the cells were washed with PBS and incubated in complete media.
ELISA for BMP2 and VEGF expression
The levels of BMP2 and VEGF secreted from transfected BMSCs and EPCs were determined by BMP2 ELISA kit and VEGF ELISA kit (R&D system, Minneapolis, USA), respectively. The supernatant of the transfected EPCs and BMSCs was harvested at the 2, 7, 14, 21, and 28 days after transduction. Ad-GFP-transfected and non-transfected EPCs and BMSCs were used as the controls. The assay was performed according to the supplier's instructions. The absorbance was measured by a multi-label counter (Synergy HT; BioTek, Winooski, USA) at 450 nm.
Co-culture system in vitro The co-cultured cells were divided into four groups that were designated as BMSCs þ EPC group, BMSC þ Ad-VEGF-EPC group, Ad-BMP2-BMSC þ EPC group, and Ad-BMP2-BMSC þ Ad-VEGF-EPC group.
The mixed cells with a ratio of 1:1 were re-suspended in 4.5 ml of osteogenic differentiation medium (L-DMEM supplemented with 10% FBS, 100 IU/ml penicillin, 10 mg/ ml streptomycin, 10
22 mM dexamethasone, and 0.01 M b-glycerophosphate). The cells were cultured in 12-well plates, and incubated at 378C in an incubator supplied with 5% CO 2 and humid atmosphere. The medium was changed every 4 days.
Alkaline phosphatase (ALP) activity assay ALP activity was assessed by the time-dependent 4-nitrophenylphosphatehexahydrate (PNPP) method [18] . The cells (5 Â 10 4 cells/ml) were washed with PBS, scraped and lysed with 200 ml 0.1% Triton X-100 (Invitrogen Life Technologies). After centrifugation at 13,000 g for 10 min at 48C, 40 ml of supernatant extracted from each sample was added to 100 ml PNPP in each well of another 96-well plate and then incubated at 378C for 30 min. The reaction was terminated by adding 100 ml of 0.4 M NaOH and the absorbance at 405 nm was measured by using the multi-label counter.
Alizarin red staining for mineralized matrix
The cells were fixed with 70% ice-cold ethanol at 2208C for 1 h, and then stained with 40 mM pH 4.2 alizarin red S (AR-S; Sigma) for 10 min at room temperature. Mineralized matrix staining was counted under a light microscope with Â100 magnification and three areas were selected for each sample.
Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) RNA was extracted from the cells and transcribed to cDNA using M-MLV reverse transcriptase (Invitrogen Life Technologies). The real-time PCR reactions were run in triplicate in an iCycler iQ Real-Time PCR Detection System (Bio-Rad, Veenendaal, The Netherlands). Thermal cycling parameters were as follows: an initial incubation of 958C for 30 s, and then 40 cycles of 958C for 5 s and 558C for 20 s, and 728C for 15 s. PCR amplification of cDNA was performed using the rat-specific primer sets listed in Table 1 . Id1 gene and the osteoblast-related genes including collagen type I (Col I), osteocalcin (OC), and ALP were amplified. A 2 244Ct method was used to evaluate the relative expression level of mRNA for each target gene.
Co-culture cells/alginate gel mixture The co-culture cells were pooled to a total of 1 Â 10 6 cells/ ml, resuspended in 1.2% low-viscosity alginate (Invitrogen Life Technologies) with 0.15 M NaCl at a density of 2 Â 10 6 cells/ml. The 1 ml mixture was transferred to 200 ml 100 mM CaCl 2 solution at room temperature for 15 min of polymerization, and then the alginate was solidified. Alginate gel mixed with cells was implanted into lateral femoral muscle of five rats in four groups, respectively. After implantation for 4 and 6 weeks, the constructs in the rats were cut into several pieces, and immediately stored in liquid nitrogen for future histological analysis.
Histology and immunohistochemistry
The samples were decalcified in 10% formic acid, dehydrated in a gradient ethanol series, embedded in paraffin, sectioned in 4 mm thickness, and stained with hematoxylin and eosin (H&E) and sirius red. Bone and Col I areas were quantified by Image Pro Plus software (Media Cybernetics, Silver Spring, USA). The average bone areas of these sections were used for statistical analysis.
For the growth of blood vessels, 4-and 6-week tissue sections were immunohistochemically stained with rabbit anti-rat CD31 monoclonal antibody (BD Biosciences) to detect endothelial cells. Sections were incubated with anti-CD31 primary antibody (1:50 dilution) at 48C overnight, and then incubated with a secondary antibody kit (Invitrogen Life Technologies). DAB (3, 3 0 -diaminobenzidine tetrahydrochloride) was used as chromogen. Finally, the slides were counterstained with hematoxylin (Sigma). Blood vessels with CD31 staining were counted under a light microscope with Â100 magnification and three areas were selected for each sample. The average areas of Table 1 The list of primers used for real-time PCR
Gene
Forward primer Reverse primer
CD31-positive cell structures were calculated and presented as mean + SD.
Statistical analysis
All data were presented as mean + SD and statistical significance was evaluated by analysis of variance analysis using SPSS software. The statistical significance was considered at P , 0.05.
Results
VEGF overexpression promotes tube formation of EPCs and up-regulates the level of Id1 gene MNCs isolated from bone marrow were cultured in EGM-2 complete medium in the presence of endothelial specific growth factors on fibronectin-coated plates. After culture for 7-10 days, small EPC colonies were observed.
Compared with the BMSCs [ Fig. 1(A) ] which exhibited a flattened, elongated, and fibroblastic shape, the EPCs [ Fig. 1(B) ] showed spindle shape and cobblestone appearance. EPCs were characterized by measuring the expression of endothelial cell markers such as CD133 and VEGFR2, and stem cell marker CD34. Cells could be considered as the EPCs if these markers were co-expressed. The fluorescence activated cell sorting (FACS) analysis demonstrated that the population of cells with co-expression of CD34, CD133, and VEGFR2 was 22.3% + 1.6% [ Fig. 1(C) ]. Besides the immunophenotype, EPCs were also characterized by functional assays in vitro, such as the uptake of diacetylated low-density lipoprotein and tube formation. The partially adherent cells could uptake Dil-ac-LDL and be co-stained with FITC-lectin [ Fig. 1(D) ]. Moreover, the cells cultured in Matrigel revealed the formation of tube-like structures [ Fig. 1(E) ]. As shown in Fig. 1(F) , the expression of VEGF in EPCs exhibited a significant increase after transfection with Ad-VEGF. Id1 is critical to EPCs population formation and angiogenesis, and the expression of Id1 can be up-regulated by VEGF [19] . Consistent with this result, the qRT-PCR revealed that VEGF induced 7-fold increase in the expression of Id1 gene [ Fig. 1(G) ]. In the tube formation assay, the Ad-VEGF-EPC group has better ability of tube formation compared with the control group [ Fig. 1(H) ].
BMP2 overexpression regulates osteogenic differentiation of BMSCs and up-regulates the level of Id1 gene
The expression of BMP2 exhibited a significant increase in Ad-BMP2-BMSCs, as shown in Fig. 2(A) . The AR-S staining and ALP activity assay results indicated that BMP2 could accelerate osteogenic differentiation of BMSCs. As shown in Fig. 2(B,C) , at the 21st day, the positive staining in the Ad-BMP2-BMSC þ Ad-VEGF-EPC group and Ad-BMP2-BMSC þ EPC group were significantly higher than those in other groups (P , 0.05). Similarly, ALP activities in the Ad-BMP2-BMSC þ Ad-VEGF-EPC and Ad-BMP2-BMSC þ EPC groups were also higher than those of other groups (P , 0.05) [ Fig. 2(D) ]. The expression of Id1 gene was found to be up-regulated more than 5-fold in the Ad-BMP2-BMSC group [ Fig. 2(E) ].
Expression of osteoblastic gene in vitro and osteogenesis in vivo Osteoblastic gene expression of cultured cells in vitro was evaluated after transplantation for 7, 14, 21, and 28 days. ALP gene in Ad-BMP2-BMSC þ EPC, BMSC þ Ad-VEGF-EPC, and Ad-BMP2-BMSC þ Ad-VEGF-EPC groups reached a peak level at the 21st day. However, Ad-BMP2-BMSC þ EPC and Ad-BMP2-BMSC þ Ad-VEGF-EPC groups showed higher ALP expression than other groups (P , 0.05) [ Fig. 3(A) ]. All groups showed slow increase in the expression of OC [ Fig. 3(B) ]. Interestingly, the Col I expression in all groups increased time dependently, and the Ad-BMP2-BMSC þ Ad-VEGF-EPC group had the highest Col I level at the 21st day (P , 0.05) [ Fig. 3(C) ].
For in vivo study, after implantation for 4 weeks, decalcified sections stained with H&E and sirius red from all groups exhibited ectopic bone formation and Col I formation. The volume of the alginate gel became smaller and Ad-BMP2-BMSC þ Ad-VEGF-EPC group and Ad-BMP2-BMSC þ EPC group showed higher ALP activity than the others groups at 21st day. Data were presented as mean + SD (n ¼ 3). *P , 0.05 compared with BMSC þ EPC and BMSC þ Ad-VEGF-EPC groups. (E) The expression of Id1 gene was up-regulated more than 5-fold in Ad-BMP2-BMSC group. *P , 0.05 compared with BMSC and Ad-GFP -BMSC groups.
smaller due to the degradation and absorption by host tissues. Long-round or shuttle-like cells were observed along the alginate gel. Many neo-collagen tissues and irregular premature bone-like matrix were also observed on the interface between alginate gel and tissues. Newly formed bone began to cover the surface of scaffolds in all groups after 4 weeks. At week 6, the alginate scaffold still remained in vivo, as shown in Fig. 3(D) , and more collagen tissues were observed [ Fig. 3(E) ]. The quantitative analysis showed that Ad-BMP2-BMSC þ EPC and Ad-BMP2-BMSC þ Ad-VEGF-EPC groups had higher bone area than others at week 4 and 6, and there was significant difference between these two groups at week 6 (P , 0.05) [ Fig. 3(F) ]. The amount of Col I formation in Ad-BMP2-BMSC þ EPC and Ad-BMP2-BMSC þ Ad-VEGF-EPC groups were higher than those in the BMSCs þ EPC and BMSC þ Ad-VEGF-EPC groups at week 4 and 6, but there was no significant difference between Ad-BMP2-BMSC þ EPC and Ad-BMP2-BMSC þ Ad-VEGF-EPC groups (P , 0.05) [ Fig. 3(G) ].
Angiogenesis in vivo
The occurrence of angiogenesis at the 4th and 6th week was confirmed by the expression of CD31, a special marker of endothelial cells. The BMSC þ Ad-VEGF-EPC and Ad-BMP2-BMSC þ Ad-VEGF-EPC groups displayed higher density of blood vessels than other groups at week 4 and 6, and there was significant difference between these two groups at week 6 (P , 0.05) [Fig. 4(A) ], which was also verified by the quantitative analysis for blood vessel density [ Fig. 4(B) ].
Discussion
Bone remodeling is a complex process involving angiogenesis and osteogenesis. The correlation between angiogenesis and osteogenesis may offer an exciting therapeutic opportunity for bone regeneration. The understanding of the cellular and molecular interactions in blood vessels and bone cells will be helpful for successful development of vascularized bone scaffold constructs that will offer the survival and integration of bioengineered bone with the host tissues [20] .
Bone marrow-derived EPCs are critical regulators of the angiogenic switch [21] and VEGF is one of the most effective angiogenic growth factors for both physiological and pathological angiogenesis [3, 22] . Early and late EPCs are two major types of EPCs. Early EPCs have a short lifespan and reveal a gradual loss of endothelial cell-specific markers such as CD133. Compared with the early EPCs, late EPCs have a similar gene expression profile as the endothelial cells and a long lifespan as well as rapid proliferation [10, 23] . Based on characterization of EPCs, the late EPCs have been chosen as the seed cells in our present study. VEGF-modified EPCs constitute one option to address the limited number of EPCs. Iwaguro et al. [13] demonstrated that the dose of EPCs used for the in vivo experiments was 30 times less than that required in previous trials of EPC transplantation to improve ischemic limb salvage. In our study, modified EPCs with overexpression of VEGF revealed an efficient increase of blood vessel density in vivo. Moreover, VEGF can up-regulate the expression of Id1 gene which is a critical positive factor in the EPCs, including recruitment, chemotaxis, and mobilization of EPCs [24] . Loss of Id1 led to a complete loss of the EPC populations in the peripheral blood, which was correlated with a block of neovascularization [25] . Previous studies demonstrated that cultured mesenchyme cells genetically modified with adenovirus-BMP2 could produce orthotopic bone in animal models [8, 26] . The defects treated with adenovirus-BMP2-transduced cells had an increased density of trabecular bone and an obvious improvement of bone formation. However, we did not observe increase in the expression level of osteoblastic genes (ALP, OC, and Col I) or ectopic bone formation in the Ad-BMP2-BMSC þ Ad-VEGF-EPC group at the late time. To gain insight into the reason of this phenomenon, we detected the level of Id1 in BMSCs and found that BMP2 significantly up-regulated expression of Id1 gene. However, according to a previous study from Nakashima et al. [27] , Id1 protein might promote proliferation of early osteoblast progenitor cells and down-regulated the terminal differentiation of committed osteoblasts. In this regard, we proposed the overexpression of Id1 induced by BMP2 maybe the reason for this phenomenon.
The vascularization of the scaffold is one of the promising strategies in regenerative medicine, such as co-cultured the vascular endothelial cells and bone cells or mesenchymal stem cells in the scaffold [28, 29] . EPCs and BMSCs were the powerful candidate cell types for bone regeneration [30, 31] . Cell-to-cell communication between bone vascular endothelium and osteoblasts could be crucial to the coordinated cell behavior, which was necessary for the development and regeneration of bone [32] . Regarding the mode of cell-to-cell communication, cell-soluble factors have been identified and can be used to explain the biological effect on both cell types. VEGF and BMP2 are the necessary factors for osteo-endothelial communication [33] [34] [35] . In our study, EPCs and BMSCs were transduced with adenovirus encoding VEGF and BMP2, respectively, and the expression of BMP2 and VEGF revealed a significant increase. The expression of Id1 may be further up-regulated by this synergistic effect, and result in undesired bone formation in the combinatorial group.
Co-cultured EPCs and BMSCs with genetic modifications could enhance the communication between cells and achieve a synergistic effect between VEGF and BMP2. Therefore, VEGF-EPCs and BMP2-BMSCs were powerful candidate cell types for engineered bone tissues. This cell-based and gene-based approach seems feasible due to the following advantages: (i) BM -EPCs and BMSCs are easy to be harvested and cultivated; (ii) high transduction efficiency of transgene can effectively augment cellular functions. This study has demonstrated that VEGF-EPCs and BMP2-BMSCs could enhance bone formation through efficient angiogenesis, although the desired results are not achieved. According to previous studies and our data, we consider that the elevated expression of Id1 gene may retard the terminal differentiation of osteoblasts, and even the bone formation. This finding suggests that a Figure 4 Angiogenesis in vivo at 4 and 6 weeks after implantation (A) Immunohistochemistry of CD31 at 6 weeks after implantation. Arrows indicated CD31-positive staining. Bar ¼ 50 mm. (B) Quantitative analysis of blood vessel density at 4 and 6 weeks after implantation. Ad-BMP2-BMSC þ Ad-VEGF -EPC group had significantly higher blood vessel density than other groups. Data were presented as mean + SD (n ¼ 5). *P , 0.05 compared with BMSC þ EPC and Ad-BMP2 -BMSC þ EPC groups; # P , 0.05 compared with other three groups.
Synergism of BMP2 and VEGF in bone regeneration balanced regulation of Id1 expression in VEGF-EPCs and BMP2-BMSCs may be critical to cell-based and genebased approaches for bone regeneration.
In conclusion, VEGF-modified EPCs co-cultured with BMP2-modified BMSCs can accelerate osteogenesis and bone formation through promoting the vascularization of transplant tissues. Although this approach did not exhibit perfect bone formation, the relationship between Id1 gene and osteogenesis has the potential to provide a new vision for the engineered bone tissues.
